Should You Buy Monro Inc (MNRO) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
18.720
1 Day change
-1.42%
52 Week Range
21.770
Analysis Updated At
2026/01/30
MNRO is a BUY right now (pre-market ~19.38) for an impatient, near-term rebound setup: the stock is deeply oversold (RSI~19.7) and sitting just above first support (~19.21), with recent earnings showing resilience (EPS beat, comp sales +1.2%) and hedge funds increasing buying sharply QoQ. This is more of a tactical bounce/swing buy than a trend-following entry because momentum (MACD) is still deteriorating.
Technical Analysis
Trend/momentum remains bearish but stretched: MACD histogram is -0.207 and negatively expanding (downtrend pressure persists). However, RSI_6 at ~19.66 signals extreme oversold conditions that often precede reflex rallies. Moving averages are converging (selling pressure may be stabilizing rather than accelerating). Key levels: immediate support S1 ~19.21 (current pre-market ~19.38 is barely above it), deeper support S2 ~18.51. Pivot ~20.34 is the first meaningful reclaim level; a move back above pivot increases odds of a bounce continuation toward R1 ~21.47.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Options positioning is mixed but active: open interest put/call ratio ~0.1 is very call-heavy (bullish longer positioning/structure), while the volume put/call ratio ~2.0 shows puts dominating today’s flow (near-term hedging or bearish speculation). Volume is elevated vs the 30-day average (today vs avg ~5.74x), implying traders are reacting strongly around the recent earnings/news and current selloff. IV is relatively moderate for the name (30D IV ~51) with IV percentile ~21, suggesting options aren’t priced at extreme panic levels.
Technical Summary
Sell
9
Buy
6
Positive Catalysts
Reported net income was highlighted as up materially in the news summary (143% to ~$11.1M), and gross margin improved YoY (~34.89%, +1.78% YoY). Hedge funds are buying, with purchase amount up ~119.6% over the last quarter, supporting a near-term sentiment floor.
Neutral/Negative Catalysts
tied to store closures, indicating top-line pressure and business transition. Price action momentum is still weak (MACD worsening), so the stock may chop or retest lower supports before any sustained recovery. The provided financial snapshot conflicts with the news on profitability (snapshot shows net income/EPS down to 0 YoY while news cites higher net income), which creates uncertainty around headline vs adjusted/accounting figures.
Financial Performance
Latest quarter: 2026/Q3. Revenue: ~$293.4M, down ~4.05% YoY (top-line contraction). Gross margin: ~34.89%, up ~1.78% YoY (profitability/merchandising improving). Profit metrics are mixed across the provided data: news notes Non-GAAP EPS beat and net income rising to ~$11.1M, while the snapshot reports net income and EPS at 0 (down 100% YoY). Net takeaway from the combined dataset: operations are holding up better than sales (margin improving, EPS beat), but growth is not yet re-accelerating.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target change data was provided, so a clear recent Street upgrade/downgrade or target revision trend cannot be confirmed from this dataset. Wall Street pros/cons view based on available info: Pros—earnings resilience (EPS beat), improving gross margin, and increased hedge fund buying. Cons—revenue decline/store closures and bearish near-term technical momentum.
Wall Street analysts forecast MNRO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MNRO is 20 USD with a low forecast of 20 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast MNRO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MNRO is 20 USD with a low forecast of 20 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 18.990
Low
20
Averages
20
High
20
Current: 18.990
Low
20
Averages
20
High
20
Wells Fargo
David Lantz
Equal Weight
maintain
$15 -> $18
AI Analysis
2025-10-21
Reason
Wells Fargo
David Lantz
Price Target
$15 -> $18
AI Analysis
2025-10-21
maintain
Equal Weight
Reason
Wells Fargo analyst David Lantz raised the firm's price target on Monro to $18 from $15 and keeps an Equal Weight rating on the shares ahead of quarterly results. The firm models +2% comparable sales in Q2, but expects additional signs of turnaround progress.
Wells Fargo
David Lantz
Equal Weight
maintain
$15 -> $16
2025-05-29
Reason
Wells Fargo
David Lantz
Price Target
$15 -> $16
2025-05-29
maintain
Equal Weight
Reason
Wells Fargo analyst David Lantz raised the firm's price target on Monro to $16 from $15 and keeps an Equal Weight rating on the shares. The bar was low, but the firm attributes Monro outperformance to the positive Q4 comp inflection, accelerating quarter-to-date trends, and color around 4 focus areas for improvement. Wells is reluctant to chase as turnarounds are rarely linear and a heavy lift remains.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MNRO
